Mirum Pharmaceuticals, Inc. (MIRM)
93.33
-1.28
(-1.35%)
USD |
NASDAQ |
Nov 12, 16:00
93.22
-0.11
(-0.12%)
After-Hours: 20:00
Mirum Pharmaceuticals Market Cap : 6.086B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 6.086B |
| November 11, 2026 | 6.169B |
| November 10, 2026 | 6.157B |
| November 09, 2026 | 6.076B |
| November 06, 2026 | 6.111B |
| November 05, 2026 | 6.100B |
| November 04, 2026 | 6.323B |
| November 03, 2026 | 5.675B |
| November 02, 2026 | 5.591B |
| October 30, 2026 | 5.543B |
| October 29, 2026 | 5.594B |
| October 28, 2026 | 5.557B |
| October 27, 2026 | 5.540B |
| October 26, 2026 | 5.392B |
| October 23, 2026 | 5.206B |
| October 22, 2026 | 5.381B |
| October 21, 2026 | 5.403B |
| October 20, 2026 | 5.509B |
| October 19, 2026 | 5.325B |
| October 16, 2026 | 5.189B |
| October 15, 2026 | 5.335B |
| October 14, 2026 | 5.178B |
| October 13, 2026 | 5.156B |
| October 12, 2026 | 5.573B |
| October 09, 2026 | 5.570B |
| Date | Value |
|---|---|
| October 08, 2026 | 5.268B |
| October 07, 2026 | 5.222B |
| October 06, 2026 | 5.132B |
| October 05, 2026 | 5.273B |
| October 02, 2026 | 5.370B |
| October 01, 2026 | 5.434B |
| September 30, 2026 | 5.535B |
| September 29, 2026 | 5.669B |
| September 28, 2026 | 5.696B |
| September 25, 2026 | 5.808B |
| September 24, 2026 | 5.786B |
| September 23, 2026 | 5.784B |
| September 22, 2026 | 5.918B |
| September 21, 2026 | 5.957B |
| September 18, 2026 | 5.946B |
| September 17, 2026 | 6.399B |
| September 16, 2026 | 6.305B |
| September 15, 2026 | 6.080B |
| September 14, 2026 | 6.265B |
| September 11, 2026 | 6.360B |
| September 10, 2026 | 6.515B |
| September 09, 2026 | 6.365B |
| September 08, 2026 | 6.445B |
| September 04, 2026 | 6.534B |
| September 03, 2026 | 6.516B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 24.83B |
| Galectin Therapeutics, Inc. | 208.22M |
| TG Therapeutics, Inc. | 9.759B |
| Ardelyx, Inc. | 783.22M |
| Kodiak Sciences, Inc. | 6.801B |
Market Cap Related Metrics
| PS Ratio | 8.326 |
| PEG Ratio | -0.0037 |
| Price | 93.33 |
| Earnings Yield | -16.31% |
| PEGY Ratio | -0.0037 |